KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Construction in Progress (2016 - 2026)

Bristol Myers Squibb has reported Construction in Progress over the past 12 years, most recently at $1.5 billion for Q1 2026.

  • Quarterly Construction in Progress fell 6.94% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Mar 2026, down 6.94% year-over-year, with the annual reading at $1.6 billion for FY2025, 6.16% up from the prior year.
  • Construction in Progress was $1.5 billion for Q1 2026 at Bristol Myers Squibb, down from $1.6 billion in the prior quarter.
  • Over five years, Construction in Progress peaked at $1.8 billion in Q2 2025 and troughed at $800.0 million in Q1 2022.
  • The 5-year median for Construction in Progress is $1.2 billion (2024), against an average of $1.3 billion.
  • Year-over-year, Construction in Progress soared 54.14% in 2022 and then decreased 6.94% in 2026.
  • A 5-year view of Construction in Progress shows it stood at $1.1 billion in 2022, then grew by 2.09% to $1.1 billion in 2023, then skyrocketed by 41.86% to $1.5 billion in 2024, then grew by 6.16% to $1.6 billion in 2025, then fell by 4.82% to $1.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Construction in Progress are $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025).